-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Sonpiretigene Isteparvovec in Juvenile Macular Degeneration (Stargardt Disease)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Sonpiretigene Isteparvovec in Juvenile Macular Degeneration (Stargardt Disease) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Sonpiretigene Isteparvovec in Juvenile Macular Degeneration (Stargardt...
-
Analyst Opinions
NewUnited Kingdom (UK) General Election – Sentiment and Consumer Insights
United Kingdom (UK) General Election Sentiment and Consumer Insights Report Overview Over 41% of consumers stated they intend to vote Labour on 4 July, a 17.3ppts lead on the Conservatives. Value players’ shoppers intend to vote red in the upcoming Election. Consumers who regularly shop at value retailers, Lidl and Aldi, have swayed more heavily towards Labour in 2024, with value shoppers previously being Conservative in the 2019 Elections. With younger consumers feeling more confident, this indicates a stark difference...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Vatiquinone in Friedreich Ataxia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Vatiquinone in Friedreich Ataxia report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Vatiquinone in Friedreich Ataxia Drug Details: Vatiquinone (EPI-743) is under development...
-
Product Insights
Likelihood of Approval Analysis for Hemoglobinuria
Overview How likely is it that the drugs in Hemoglobinuria will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Hemoglobinuria Overview Hemoglobinuria is a condition characterized by the presence of free hemoglobin...
-
Product Insights
NewQuarterly Baking Ingredients pricing trends in Qatar
Empower your strategies with our Quarterly Baking Ingredients pricing trends in Qatar report and make more profitable business decisions. Consumers’ preferences for stores are most heavily influenced by pricing and promotions, but brands and retailers continue to adjust prices and promotions based on insufficient information from expensive, drawn-out, and incomplete audits of rival techniques. Brands and retailers can benefit from the unique intelligence provided by GlobalData Ecommerce Price Tracker, covering millions of SKUs, to identify, anticipate, and implement important business...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Vatiquinone in Subacute Necrotizing Encephalomyelopathy (Leigh Disease)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Vatiquinone in Subacute Necrotizing Encephalomyelopathy (Leigh Disease) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Vatiquinone in Subacute Necrotizing Encephalomyelopathy (Leigh Disease) Drug...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Vatiquinone in MELAS Syndrome (Mitochondrial Encephalomyopathy, Lactic Acidosis and Stroke-Like Episodes)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Vatiquinone in MELAS Syndrome (Mitochondrial Encephalomyopathy, Lactic Acidosis and Stroke-Like Episodes) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Vatiquinone in MELAS Syndrome...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Vatiquinone in Epilepsy
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Vatiquinone in Epilepsy report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Vatiquinone in Epilepsy Drug Details: Vatiquinone (EPI-743) is under development for the...
-
Product Insights
Likelihood of Approval Analysis for Iron Deficiency Anemia
Overview How likely is it that the drugs in Iron Deficiency Anemia will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Iron Deficiency Anemia Overview Anemia is a condition in which the...
-
Product Insights
Likelihood of Approval Analysis for Acquired (Autoimmune) Hemolytic Anemia
Overview How likely is it that the drugs in Acquired (Autoimmune) Hemolytic Anemia will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Acquired (Autoimmune) Hemolytic Anemia Overview Acquired autoimmune hemolytic anemia (AIHA)...